Penn Medicine Provider
Infectious Diseases
Ingi Lee, MD, MSCE
5.0
(66)
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program

About me

  • Assistant Director, Transplant ID Program
  • Associate Professor of Clinical Medicine (Infectious Diseases)

Education and training

  • Medical School: Yale University
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

66 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
5.0
5.0
she took her time very informative careing doctor
February 2025
5.0
5.0
happy with our appointment
January 2025
5.0
5.0
excellent provider, helpful, knowledgeable, respectful
December 2024
5.0
5.0
well pleased with dr.lee

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Lee is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Knox JJ, Lee I, Blumberg E, Rosenfeld AM, Meng W, Liu F, Kearns C, O'Doherty U, Shaked A, Olthoff KM, and Luning Prak ET B cell subset representation predicts COVID-19 vaccine response in solid organ transplant recipients , The Journal of Infectious Diseases: 2025


Vinayak Ahluwalia, BSE; Sana Dastgheyb, MD, PhD; Mark Diamond, MD, PhD; Ingi Lee, MD, MSCE; Ima Paydar, MD; Keith Cengel, MD, PhD Shingles After a Single Fraction of Radiation for Ewing Sarcoma , Applied Radiation Oncology, 11(3): 2022


Wang R, Longworth SA, Doyon JB, Lee I, Bloom R, Romano CM, Veasey SL, Blumberg EA Active tuberculosis after solid organ transplantation in individuals with negative pretransplant quantiferon-TB gold testing: a case series , Transplantation Proceedings: 2022


Andrew Courtwright, Sarah Longworth, Donna Chojnowski, Ingi Lee, and Stephen Hunt Treatment of a pulmonary aspergilloma in a lung transplant recipient using catheter-directed intracavitary instillation of liposomal amphotericin B , Transplantation Direct: 2021


Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Žák P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A; V212 Protocol 001 Trial Team Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial , Lancet, 391(10135): 2018,2116-2127


Suh B, Suh JJ, Lee I, Shapiro T, Axelrod P, Truant AL A quantitative in vitro determination of relative phototoxic potential of quinolone antibiotics , Int J Pharm Sci & Scient Res, 3(2): 2017,45-48


Sahoo F, Hill JA, Xie H, Leisenring W, Yi J, Goyal S, Kimball LE, Lee I, Seo S, Davis C, Pergam SA, Flowers ME, Liaw K-L, Holmberg L, Boeckh M Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies , Biol Blood Marrow Transplant, 23(3): 2017,505-511


Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study , Transplant Infect Dis, 16(1): 2014,76-83


Seem DL, Lee I, Umscheid CA, Kuehnert MJ Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation , Am J Transplant, 13(8): 2013,1953-62


Seem DL, Lee I, Umscheid CA, Kuehnert MJ Public Health Service (PHS) Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Transmission Through Organ Transplantation , Public Health Reports , 128(4): 2013,247-343